Cargando…
Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is the most common inherited mitochondrial metabolic disease of fatty acid β-oxidation, especially in newborns. MCADD is clinically diagnosed using Newborn Bloodspot Screening (NBS) and genetic testing. Still, these methods have limitations, suc...
Autores principales: | Sebaa, Rajaa, AlMogren, Maha, Alseraty, Wafaa, Abdel Rahman, Anas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253986/ https://www.ncbi.nlm.nih.gov/pubmed/37298607 http://dx.doi.org/10.3390/ijms24119657 |
Ejemplares similares
-
A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns
por: Sebaa, Rajaa, et al.
Publicado: (2023) -
Comparison of dried blood spot and plasma sampling for untargeted metabolomics
por: Tobin, Nicole H., et al.
Publicado: (2021) -
Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening
por: Maier, Esther M., et al.
Publicado: (2009) -
Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023) -
Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency
por: van Dooijeweert, Birgit, et al.
Publicado: (2020)